Stay informed with the latest litigation news. Explore now

IP Verse

Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv - EP2322930B1

EP2322930

BECTON DICKINSON INFUSION THERAPY SYSTEMS
Application Number
EP10016074A
Filing Date
Oct 10, 2006
Status
Granted And Under Opposition
Jun 11, 2021
Grant Date
Jul 14, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2325643B1
EP2325647B1
EP2325644B1

Bibliography

The patent EP2322930B1 was granted to Becton Dickinson Infusion Therapy Systems on Jul 14, 2021 following the initial filing on Oct 10, 2006 under the application number EP10016074A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BECKMAN COULTERApr 13, 2022 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents